InvestorsHub Logo
Followers 4
Posts 239
Boards Moderated 0
Alias Born 06/19/2020

Re: None

Friday, 11/18/2022 8:18:28 AM

Friday, November 18, 2022 8:18:28 AM

Post# of 715691
Let’s just take a moment and read this slowly so that we can all fully understand how significant this is on several levels. This is going to be so easy to manufacture and deliver to patients. To the moon is an understatement.

DCVax-L is a fully personalized immune therapy made from a patient's own immune cells (dendritic cells) and antigens (biomarkers) from a sample of the patient's own tumor. A multi-year set of doses is produced in a single manufacturing batch, which takes 8 days. The product is then stored frozen in individual doses, and is "off the shelf" throughout the treatment regimen. The doses are stored centrally and simply taken out of the freezer and delivered to the physician when needed for the patient's next treatment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News